• Join
  • Login
  • Contact

Search abstracts

Regulatory perspective in safety and efficacy of new drug approval

  • At: 2011 FIP Congress in Hyderabad (India)
  • Type: Presentation
  • By: KAMBOJ, Rajender (Lupin Ltd., Pune, India)
  • Abstract:

    New drug development process is becoming increasingly tougher. R&D timelines & costs are consistently rising. Adding to this challenge, drugs are getting withdrawn from the market & there is a growing expectation of all stakeholders from regulatory authorities to approve safer drugs. Like never before, the drug development and approval process


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses